Search

everythinglearnresearchcommunity

for

Search:↓

Hirsutism can lower a woman's quality of life, causing emotional distress and affecting social and work opportunities.

PCOS may have evolved as an advantage in past environments with food scarcity.

Women with effluvium have higher levels of certain urinary steroids, possibly due to stress and increased adrenal activity.

A certain gene variation is linked to a higher risk of polycystic ovarian syndrome in South Indian women.

Caffeine can potentially treat common hair loss by counteracting hair follicle shrinkage caused by hormones.

Early diagnosis and treatment, using finasteride, minoxidil, or hair transplantation, improves hair loss outcomes.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

Lower SHBG levels may increase the risk of PCOS.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Finasteride is a safe, effective treatment for hirsutism with fewer side effects.

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

PCOS in teens is hard to diagnose, linked to genetics and lifestyle, and managed with weight loss and medication.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

Women with PCOS are more likely to have sleep apnea, mainly if they are obese.

Patients with PCOS rate their hirsutism higher than clinicians, and these self-ratings are more closely related to their quality of life and risk of depression.

The research suggests that the global distribution of PCOS is likely due to historical human migration and that genes affecting PCOS may have different impacts on males and females.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.

Female hair loss linked to metabolic syndrome, not in males.

Metformin should be used for PCOS mainly in those with glucose intolerance, and has limited benefits for infertility or hirsutism.

Combining laser hair removal with topical eflornithine is recommended for better results in treating unwanted facial hair.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Acne is common in women, often hormone-related, negatively affects quality of life, and requires various treatments.